Cessation

August 30, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Subject: Intimation regarding completion of term of Independent Director Ref.: Regulation 30 and 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) With reference to the captioned subject, we wish to inform you that Mr. Bharat Anand (DIN: 02806475) has completed his second term as an Independent Director of the Company and consequently, has ceased to be an Independent Director of the Company with effect from August 30, 2026. Accordingly, Mr. Bharat Anand has also ceased to be a member of the following Board Committees: 1. Audit Committee; 2. Nomination and Remuneration Committee; 3. Risk Management Committee; and 4. Corporate Social Responsibility Committee. The Board of Directors and the Management of the Company place on record their sincere appreciation for the valuable contribution, guidance and support provided by Mr. Bharat Anand during his association with the Company as an Independent Director. The details as required under the Listing Regulations, read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (“SEBI Master Circular”), are enclosed herewith as Annexure-I. You are requested to kindly take the above information on your records. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer Encl.: A/a Annexure-I Details as required under Regulation 30 of Listing Regulations read with SEBI Master Circular: S. No. Particulars Details 1 Reason for change viz. appointment, re- Cessation due to completion of his second appointment, resignation, removal, death or term. otherwise 2 Date of appointment / re-appointment / August 30, 2026 cessation (as applicable) & term of appointment/re-appointment 3 Brief profile (in case of appointment) Not Applicable 4 Disclosure of relationships between directors Not Applicable (in case of appointment of a director)